Suchergebnisse - "Janus Kinases"

PubPharm (16.026)

1

Upadacitinib for the treatment of adult patients with active psoriatic arthritis

enthalten in: Expert review of clinical immunology | 2024

von Marchesoni, A. | Citriniti, G. | Girolimetto, N. | +2

2

Tofacitinib for managing granuloma formation after dermal filler injection : three case reports and literature review

enthalten in: The Journal of dermatological treatment | 2024

von Wang, J. | Chen, Z. | Wu, L. | +2

3

Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer

enthalten in: Nature communications | 2024

von Raymant, M. | Astuti, Y. | Alvaro-Espinosa, L. | +13

4

Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Arthritis care & research | 2024

von Singh, N. | Gold, L. | Lee, J. | +9

5

Access to biologics and Janus kinase inhibitors for treatment of rheumatic diseases in the biosimilars era in Poland : a nation-level study

enthalten in: Polish archives of internal medicine | 2024

von Stajszczyk, M. | Kwiatkowska, B. | Żuber, Z. | +1

6

Sokotrasterol Sulfate Suppresses IFN-γ-Induced PD-L1 Expression by Inhibiting JAK Activity

enthalten in: Journal of natural products | 2024

von Wang, X. | Xu, W. | Wang, Z. | +10

7

Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis : A Real-World Clinical Practice in Japan

enthalten in: Clinical drug investigation | 2024

von Hagino, T. | Hamada, R. | Yoshida, M. | +3

8

Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno-inflammatory diseases

enthalten in: CPT: pharmacometrics & systems pharmacology | 2024

von Maleki, F. | Clark, E. | Banfield, C. | +2

9

Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms

enthalten in: Experimental hematology | 2024

von Collins, T. | Laranjeira, A. | Kong, T. | +5

10

Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR

enthalten in: Cancer medicine | 2024

von Wang, Z. | Tian, X. | Ma, J. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1603]